ID: ALA5274952

Max Phase: Preclinical

Molecular Formula: C20H21ClN2

Molecular Weight: 324.86

Associated Items:

Representations

Canonical SMILES:  CNCc1cc(-c2ccccc2Cl)n(-c2ccc(C)cc2)c1C

Standard InChI:  InChI=1S/C20H21ClN2/c1-14-8-10-17(11-9-14)23-15(2)16(13-22-3)12-20(23)18-6-4-5-7-19(18)21/h4-12,22H,13H2,1-3H3

Standard InChI Key:  POUAPEPLGNWXJD-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin transporter 12625 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.86Molecular Weight (Monoisotopic): 324.1393AlogP: 5.13#Rotatable Bonds: 4
Polar Surface Area: 16.96Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.29CX LogP: 5.38CX LogD: 3.50
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: -0.99

References

1. Wunnava AUR, Kurati SP, Eswar Kumar K, Muthyala MKK..  (2023)  Design, synthesis and evaluation of 1-(1,5-bis(4-substituted phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors with potential antidepressant action.,  14  (2.0): [PMID:36846366] [10.1039/d2md00243d]

Source